Acute myeloid leukemia laboratory tests: Difference between revisions

Jump to navigation Jump to search
Line 20: Line 20:


* Renal function tests
* Renal function tests
* Coagulation studies - prolonged bleeding and clotting time


* [[Bone marrow examination]] - is often performed to identify the type of abnormal blood cells; however, if there are many leukemic cells circulating in the peripheral blood, a bone marrow [[biopsy]] may not be necessary.
* [[Bone marrow examination]] - is often performed to identify the type of abnormal blood cells; however, if there are many leukemic cells circulating in the peripheral blood, a bone marrow [[biopsy]] may not be necessary.
Line 35: Line 37:
| [[Image:AML (with Auer Rods).jpg|thumb|AML (with Auer Rods)]]
| [[Image:AML (with Auer Rods).jpg|thumb|AML (with Auer Rods)]]
|}
|}
===Fluorescent in situ hybridization===
Because [[acute promyelocytic leukemia]] (APL) has the highest curability and requires a unique form of treatment, it is important to quickly establish or exclude the diagnosis of this subtype of leukemia. [[Fluorescent in situ hybridization]] performed on blood or bone marrow is often used for this purpose, as it readily identifies the [[chromosomal translocation]] (t&#91;15;17&#93;) that characterizes APL.<ref>{{cite journal | author = Grimwade D, Howe K, Langabeer S, Davies L, Oliver F, Walker H, Swirsky D, Wheatley K, Goldstone A, Burnett A, Solomon E | title = Establishing the presence of the t(15;17) in suspected acute promyelocytic leukaemia: cytogenetic, molecular and PML immunofluorescence assessment of patients entered into the M.R.C. ATRA trial. M.R.C. Adult Leukaemia Working Party. | journal = Br J Haematol | volume = 94 | issue = 3 | pages = 557-73 | year = 1996 | pmid = 8790159}}</ref>


==References==
==References==

Revision as of 19:15, 8 August 2012

Acute myeloid leukemia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Acute myeloid leukemia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardigram

Chest X Ray

Echocardiograph and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Acute myeloid leukemia laboratory tests On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Acute myeloid leukemia laboratory tests

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Acute myeloid leukemia laboratory tests

CDC on Acute myeloid leukemia laboratory tests

Acute myeloid leukemia laboratory tests in the news

Blogs on Acute myeloid leukemia laboratory tests

Directions to Hospitals Treating Acute myeloid leukemia

Risk calculators and risk factors for Acute myeloid leukemia laboratory tests

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Raviteja Guddeti, M.B.B.S. [2]

Overview

Laboratory Findings

  • Peripheral blood smear - immature blast cells can be identified
  • Liver function tests
  • Renal function tests
  • Coagulation studies - prolonged bleeding and clotting time
  • Bone marrow examination - is often performed to identify the type of abnormal blood cells; however, if there are many leukemic cells circulating in the peripheral blood, a bone marrow biopsy may not be necessary.

Marrow or blood is examined via light microscopy as well as flow cytometry to diagnose the presence of leukemia, to differentiate AML from other types of leukemia (e.g. acute lymphoblastic leukemia), and to classify the subtype of disease.

The diagnosis and classification of AML can be challenging, and should be performed by a qualified hematopathologist or hematologist. In straightforward cases, the presence of certain morphologic features (such as Auer rods) or specific flow cytometry results can distinguish AML from other leukemias; however, in the absence of such features, diagnosis may be more difficult.[1]

AML - Auer Rods, DIC
AML (with Auer Rods)

References

  1. Abeloff, Martin et al. (2004), p. 2835.

Template:Hematology



Template:WikiDoc Sources